Venus Concept Corporation (VERO) - Koefisien utang jangka dawa marang modal

Lambang korporat lan logo Venus Concept Inc. (VERO)

This price chart for Venus Concept Inc. (VERO) captures the indicator at 0.00. Production efficiency is declining due to underutilized capacity and debt. Management is currently conducting a deep restructuring of processes and sales optimization to return to profitability. Meanwhile, the business leads in the creation of non-invasive appearance correction systems, replacing surgical operations with affordable cosmetic procedures.

VERO Venus Concept Inc: Utang jangka dawa marang ekuitas ing interval 04.07.2022 - 21.02.2026
Barang utama Venus Concept Corporation

The indicator is calculated as the ratio of liabilities with a maturity of more than one year to equity. This metric determines the extent to which long-term financing depends on shareholders' funds, identifying risks of excessive leverage. For Venus Concept Inc. (VERO), the balance of borrowings is critical due to the dependence of equipment sales on consumer demand. Analyzing the long-term debt-to-equity ratio allows for an assessment of the company's resilience to revenue fluctuations. A low leverage level here serves as a guarantee of solvency.

Perusahaan pesaing

DXCM (DexCom Inc) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal PEN|NOVT (Novanta Photonics) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Kewajiban jangka dawa marang modal|PRCT - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CNMD (CONMED Corp)|PLSE: Utang jangka dawa marang modal|InMode MD (INMD) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Picard Medical Inc|surmodics.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal SENS|NPCE - Kewajiban jangka dawa marang modal|Tactile Medical - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal SANUWAVE Health Inc SNWV|OM: Rasio utang jangka dawa marang ekuitas|Electromed, Inc. - Rasio silihan jangka dawa marang modal|LNSR: Utang jangka dawa marang modal|RCEL - Rasio tanggungan utang jangka dawa marang modal|PROF (Profound Medical Corp) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Baird Medical Corp (BDMD)|Rasio utang jangka dawa marang ekuitas EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas IceCure Medical ICCM|LUNG - Rasio utang jangka dawa marang ekuitas|TELA Bio Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Cytosorbents|SRTS: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal ZYXI|ECOR (electroCore Inc) - Utang jangka dawa marang modal|Vicarious Surgical Corp (RBOT) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal IINN|Rasio utang jangka dawa marang ekuitas SeaStar Medical Holding Corp. ICU|Utang jangka dawa marang modal IRIX (IRIDEX)|Utang jangka dawa marang modal Intelligent Bio Solutions Inc INBS|XAIR - Utang jangka dawa marang ekuitas|PFSA: Utang jangka dawa marang ekuitas|SSKN (strataskinsciences.com) - Rasio utang jangka dawa marang ekuitas|GlucoTrack Inc. - Koefisien utang jangka dawa marang modal|NAOV (NanoVibronix, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal nuwellis.com NUWE|Utang jangka dawa marang ekuitas Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Tanggungan utang jangka dawa marang ekuitas|Avinger, Inc - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal BioSig Technologies Inc. BSGM|Cutera, Inc. - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal knowlabs.co KNW|Inari Medical (NARI) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas NVRO (Nevro Corp)|Utang jangka dawa marang ekuitas ReShape Lifesciences, Inc.|Rasio utang jangka dawa marang ekuitas Silk Road Medical Inc (SILK)